{Reference Type}: Journal Article
{Title}: Roles of LncRNAs in the Pathogenesis of Pulmonary Hypertension.
{Author}: Liu T;Xu S;Yang J;Xing X;
{Journal}: Rev Cardiovasc Med
{Volume}: 25
{Issue}: 6
{Year}: 2024 Jun
{Factor}: 4.43
{DOI}: 10.31083/j.rcm2506217
{Abstract}: Pulmonary hypertension (PH) is a persistently progressive, incurable, multifactorial associated fatal pulmonary vascular disease characterized by pulmonary vascular remodeling. Long noncoding RNAs (lncRNAs) are involved in regulating pathological processes such as pulmonary vasoconstriction, thickening, remodeling, and inflammatory cell infiltration in PH by acting on different cell types. Because of their differential expression in PH patients, as demonstrated by the observation that some lncRNAs are significantly upregulated while others are significantly downregulated in PH patients, lncRNAs are potentially useful biomarkers for assessing disease progression and diagnosis or prognosis in PH patients. This article provides an overview of the different mechanisms by which lncRNAs are involved in the pathogenesis of PH.